KOSDAQ · 214450
PharmaResearch
Market cap₩2.89T
PER17.35×
PBR4.27×
Foreign ownership15.68%
Avg. analyst target₩525,000
Pension summary
as of Oct 19streak1-day net sell
5D-₩900M
20D+₩4.7B
60D+₩55.1B
Foreign 20D+₩134B
Inst. 20D-₩125B
Pension daily net buy
-Cumulative net buying by investor
-선택 기간의 net buy Total · ₩100M
| Date | Close | Pension funds | Foreign | Institutions | Retail |
|---|---|---|---|---|---|
| 10/19 | 277,000 | -₩490M | -₩1.2B | +₩520M | +₩610M |
| 10/16 | 279,000 | +₩400M | -₩1.9B | +₩6.5B | -₩4.9B |
| 10/15 | 254,000 | -₩1.5B | +₩25.4B | -₩4.6B | -₩19.4B |
| 10/14 | 270,000 | +₩170M | +₩4.9B | -₩4.5B | -₩380M |
| 10/13 | 273,500 | +₩510M | +₩18.5B | -₩23.7B | +₩5.6B |
| 10/12 | 296,000 | +₩840M | +₩6.2B | +₩2.0B | -₩8.1B |
| 10/8 | 299,000 | -₩120M | +₩7.9B | -₩8.1B | +₩210M |
| 10/7 | 309,000 | +₩1.6B | +₩2.9B | -₩3.9B | +₩360M |
| 10/6 | 306,000 | -₩370M | +₩11.0B | -₩7.9B | -₩3.2B |
| 10/2 | 307,000 | -₩1.6B | +₩1.0B | -₩11.5B | +₩10.5B |
Discussion
Google-verified members · return since posting- Loading
Pension cost basis
Oct 19 Close · positions since 2024Pension cost basis349,727
Price vs. cost-20.8%
Holding value₩163B
Last 20 days+₩4.7B
Bought in the last 6 months only: avg. cost ₩349,727.
All pension cost data →세력 매집
last 60 trading days · Oct 19Foreign 60D+₩326B
Pension funds 60D+₩55.1B
세력 Avg. cost357,942
vs. cost Close-22.6%
Foreign+Pension funds Total 시총의 +13.3%, 60D price 폭 58%·Chg -15.3%. 세력 Avg. cost net buy한 날의 Avg 매수단가로 낸 est.치예요.
세력 매집 구간 All →ETF
ETFs holding it in their top 10 · recent changes10/08 이후 큰 ETF 변화는 없어요
ETFs holding the most
- KoAct 바이오헬스케어 Active4.8%
Recent filings
DART- Loading
Broker price targets
Recent 1YAvg556,250
High690,000
Low450,000
| Broker | Rating | Target | vs prior | Date |
|---|---|---|---|---|
| Mirae Asset Securities | Buy | 600,000 | Unch. | 26.08.18 |
| IBK Securities | Buy | 530,000 | New | 26.08.10 |
| Kyobo Securities | Buy | 530,000 | Unch. | 26.08.10 |
| Daishin Securities | Buy | 620,000 | Unch. | 26.08.10 |
| Shinhan Securities | Buy | 510,000 | ▲19% | 26.08.10 |
| Yuanta Securities Korea | Buy | 450,000 | Unch. | 26.08.10 |
| Kiwoom Securities | Buy | 520,000 | ▲2% | 26.08.10 |
| Hana Securities | Buy | 690,000 | New | 26.02.05 |
Recent reports
- Asia 견문록: 다각화의 힘은 더 강해질 것Mirae Asset Securities · 08/18
- 예상보다 더 잘되고 있다IBK Securities · 08/10
- 2Q26 Review; 가이던스 부담 없고, Value 매력도는 높다Kyobo Securities · 08/10
- 리쥬란은 억울하다Daishin Securities · 08/10
- 2Q 좋고, 2H 더 좋아요Shinhan Securities · 08/10
Latest report per broker in the past year · Source: Naver Securities Research, Hankyung Consensus · Analyst names masked
Same sector
PharmaResearch summary
PharmaResearch (214450). Pension funds: +₩4.7B over the last 20 trading days; 1-day net selling streak. Market cap ₩2.89T, PER 17.35×, PBR 4.27×. Avg. analyst target ₩525,000. Pension flows are based on Korea Exchange investor statistics, for reference only.